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Abstract 
Background: Although the resuscitation of an adult trauma patient has been researched and 
written about for the past century, the ideal fluid strategy to infuse during the initial 
resuscitation period remains unresolved. This work was aimed at assessing the effect of 
hypotensive versus conventional resuscitation strategies in traumatic hemorrhagic shock 
patients on mortality, and the need for blood transfusions  including adverse events. 
Methods: This systematic review and meta-analysis were performed following the PRISMA 
guidelines. Electronic databases were searched for randomized controlled trials (RCT) 
comparing the effect of hypotension versus conventional fluid resuscitation for traumatic 
hemorrhagic shock patients. Two reviewers independently performed the screening, data 
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extraction, and bias assessment. The data analysis was completed using the Cochrane 
Collaboration's software RevMan 5.4. 
Results: Data from 28 RCTs on 4503 patients were included in the final meta-analysis. 
Patients receiving hypotension fluid resuscitation compared with conventional fluid 
resuscitation experienced less mortality (12.5% vs. 21.4%; RR = 0.58; 95% CI: 0.51–0.66; p 
< 0.001), fewer adverse events (10.8% vs. 13.4%; RR = 0.70; 95% CI: 0.59–0.83; p < 0.001), 
including fever acute respiratory distress syndrome (7.8% vs. 16.8%) or multiple organ 
dysfunction syndrome (8.6% vs. 21.6%). 
Conclusions: This meta-analysis showed that hypotensive fluid resuscitation significantly 
reduced the mortality of hypovolemic shock patients. Findings are low in certainty and should 
be interpreted with caution. Therefore, there is an urgent need for larger, multicenter, 
randomized trials to confirm these findings. 
Key words: fluid resuscitation, restricted fluid resuscitation, hemorrhagic shock, 
hemorrhage, meta-analysis, systematic review 
 
 
INTRODUCTION 
Trauma injury remains the leading cause of death among people aged less than 35 
years, with 40% of trauma deaths imputable to uncontrolled hemorrhagic shock or its 
consequences [1, 2]. 
Currently, fluid resuscitation is the first step in the hemodynamic management of 
traumatic hemorrhagic shock [3]. The rapid vascular access and stabilization of the 
cardiovascular system can protect the patient from the severe consequences of hypovolemic 
shock. The origins of fluid resuscitation can be traced back to the thirties of the nineteenth 
century, when Thomas Latta performed an attempt of intravenous fluid resuscitation for the 
first time [4]. In the period 1879–1881 Kroneecker and Landerer stated that in cases of blood 
loss the most valuable thing is to rapidly restore the vascular bed volume. For this purpose, 
they proposed using a normal saline solution with the addition of sugar [5, 6]. The 
development of fluid therapy was in the 1920s, when Alfred Blalock experimented with 
incremental hemorrhage to induce shock in dogs [7, 8]. In his research, Blalock used blood 
pressure (BP), cardiac output as well as blood oxygen content from left and right ventricles to 
evaluate the effect of three types of treatment: saline, transfusion and pharmacological 
treatment.  
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Applying an appropriate fluid therapy strategy may restore tissue perfusion and 
consequently oxygenation of the body. Fluid resuscitation can be carried out based on 
changes in hemodynamics, diuresis, serum lactate levels or alkaline deficit. However, 
excessive fluid resuscitation could contribute to the development of coagulopathy of trauma 
[3, 9] as well as tissue edema [10], which can lead to alterations of tissue perfusion and 
complications such as abdominal compartment syndrome or adult respiratory distress 
syndrome [11, 12]. The optimal level of BP during resuscitation of hemorrhagic shock 
patients is still debated. 
The present work aimed to assess the effect of hypotensive versus conventional 
resuscitation strategies in traumatic hemorrhagic shock patients on mortality, need for blood 
transfusion and adverse events (specifically: acute myocardial or renal failure or acute 
respiratory distress syndrome). 
 
METHODS 
This systematic review and meta-analysis adhere to the reporting guidelines of the 
Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) statement 
(Suppl. Table 1).  
 
Search strategy 
Available literature databases including EMBASE, MEDLINE, Google Scholar, 
Cochrane Central Register of Controlled Trials (CENTRAL) were searched from the 
inception of the databases until 18 June 2020. Searches were conducted independently by 2 
persons (K.S. and L.S.). English language restrictions were not used. The papers were 
restricted to those with the English language. Reference lists of eligible articles were reviewed 
and content experts were consulted with (K.J.F. and M.J.J.) to identify additional published 
reports. Incomplete data were dealt with by contacting the principal authors, when possible, to 
ask for missing or unclear information. 
The search strategy was comprised of MESH terms and keywords such as: 
“shock”OR, “hemorrhagic” OR, “trauma” OR, “injury” OR, “hypotensive resuscitation” OR, 
“limited resuscitation” OR, “fluid resuscitation” OR, “limited fluid”. To identify in-progress 
or terminated studies, clinicaltrials.gov registry was also searched.  
 
Study selection 
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This study included randomized controlled trials (RCTs) and quasi-randomized trials.  
Observational studies, case reports, studies not based on original research and studies not 
involving patients, conference papers as well as letters to the editor were excluded from the 
present study. 
 
Data extraction 
Using a standardized data extraction sheet, two authors (K.S. and L.S.) independently 
extracted data from each report included. Any discrepancies were resolved by consensus with 
the third author (J.S.). When necessary for data or article clarification, personal 
communication was made with select study authors. Baseline patient characteristics were 
extracted as well as data about each trial’s intervention, inclusion and exclusion criteria, 
mortality and adverse events. For all clinical outcomes, the number of events that occurred in 
each arm of each trial were tabulated. 
 
Quality assessment 
Two reviewers (J.S. and A.S.) independently assessed the methodological quality of 
each eligible article using the “risk of bias” assessment tool of the Cochrane Handbook [13]. 
The following domains were evaluated for RCTs: random sequence generation (selection 
bias), allocation concealment (selection bias), blinding of participants and personnel 
(performance bias), blinding of outcome assessment (detection bias), incomplete outcome 
data (attrition bias), selective reporting (reporting bias) and other bias [12]. Each was graded 
“yes”, “no”, or “unclear”, which reflected a high risk of bias, low risk of bias, and uncertain 
bias, respectively (Suppl. Fig. S1). The review authors’ judgments about each risk of bias 
item are provided in Supplementary Figure S2. The overall risk of bias for the study was 
rated ‘low’ if 7 or more domains were rated low, ‘moderate’ if 4 to 6 domains were rated low, 
and ‘high’ if 1 to 3 domains were rated low.  
 
Statistical analysis 
Statistical analysis was done by two authors (A.S. and L.S.) independently and was 
cross-validated. For continuous outcomes, mean difference (MD), and for dichotomous 
outcomes were used,  and risk ratios (RR), were calculated. All continuous data with either 
means with standard deviations (SD) or medians with interquartile ranges as reported in the 
primary study are presented. When the continuous outcome was reported in a study as 
median, range, and interquartile range, means and standard deviations using the formula 
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described by Hozo et al. [13] were estimated. For descriptive purposes, absolute and relative 
frequencies are reported for categoric variates.  
Statistical heterogeneity and inconsistency were measured by using the Cochran Q test 
and I2, respectively [14]. Odds ratios (OR) with 95% confidence intervals (CI) were 
calculated as summary statistics. The pooled OR was calculated with the Mantel-Haenszel 
method. Weighted mean differences and 95% CIs were computed for continuous variables, 
again using a fixed-effect method in cases of low statistical inconsistency (I2 ≤ 50%) and 
using a random-effect method in cases of moderate or high statistical inconsistency (I2 > 50%) 
[15]. Results were considered statistically significant at p < 0.05. Statistical analyses were 
performed with the Review Manager (version 5.4; The Nordic Cochrane Centre, The 
Cochrane Collaboration, Copenhagen, Denmark). 
 
RESULTS 
Eligible studies and their characteristics 
The flowchart of the literature search is presented in Figure 1. The initial search 
returned 432 records from all the databases. Two more studies were identified from the 
references of the relevant articles. Two hundred and ninety-six records were further screened 
by titles and abstracts and 138 duplicate articles were removed. Unrelated articles, comments, 
reviews, letters, and duplicate articles were excluded. Then 47 articles were assessed by 
accessing the full-text. Nineteen studies were excluded because of unavailable data, 
duplicates, and unrelated topics. Finally, 28 studies were included in the analysis [16–43].  
 
Assessment of quality 
The quality assessment is represented in Supplementary Figures S1 and S2. The 
method of random sequence generation was perfect in all the studies. There were high risks of 
attrition bias, lack of intention-to-treat analysis, and selective reporting. The detailed 
information about blinding and allocation concealment was insufficient in most studies. None 
of the trials included was at low risk of bias across all domains. 
 
Mortality 
Twenty-eight studies reported overall mortality [16–23]. Mortality with hypotension 
fluid resuscitation was 12.5% and was statistically significant, being smaller than with the 
conventional fluid resuscitation group – 21.4% (RR = 0.58; 95% CI: 0.51–0.66; I2 = 37%; p < 
0.001; Fig. 2). In contrast, only one study by Morrison et al. [28] indicated mortality rates 
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during the first 24 hours. According to this study, mortality for hypotension versus 
conventional fluid resuscitation varied and amounted to 13.6% vs. 21.7% respectively (RR = 
0.63; 95% CI: 0.25–1.58; p = 0.32).  
 
Adverse events 
The polled analysis showed that hypotension fluid resuscitation compared to 
conventional fluid resuscitation was associated with a lower risk of adverse events (10.8% vs. 
13.4%, respectively; RR = 0.70; 95% CI: 0.59–0.83; I2 = 52%; p < 0.001).  
The use of hypotension versus conventional fluid resuscitation showed a higher 
incidence of anemia (74.3% vs. 68.6%), thrombocytopenia (33.6% vs. 29.4%) and acute renal 
failure (8.8% vs. 8.1%). In other types of adverse events the relationship was reversed, and 
the use of hypotension fluid resuscitation was associated with a lower risk of complications 
(Table 1).  
 
Fluid balance and transfusion requirements 
Additional analysis showed that patients who were treated with hypotension fluid 
resuscitation required smaller volumes of fluids than the conventional fluid resuscitation 
group (MD = –1.02; 95% CI: –1.33, –0.71; I2 = 99%; p < 0.001; Fig. 3).  
 
Length of stay ICU/hospital 
The length of stay in the Intensive Care Unit (ICU) was reported by two studies [16, 
32]. The polled analysis did not show significant differences in the length of stay in ICU 
between the groups (MD = 0.38; 95% CI: –1.83–2.59; I2 = 73%; p = 0.74; Suppl. Fig. S3). 
Three studies indicated length of stay in hospital [16, 29, 32]. The difference between 
therapeutic groups was not statistically significant (MD = –0.82; 95% CI: –2.43–0.78; I2 = 
0%; p = 0.32; Suppl. Fig. S4).  
 
DISCUSSION 
The purpose of this research was to compare the effects of hypovolemic and 
conventional fluid resuscitation on the mortality rate among patients with traumatic 
hemorrhagic shock. Meta-analysis for overall mortality showed that hypovolemic fluid 
resuscitation offered benefit in comparison with conventional fluid resuscitation for patients 
with traumatic hemorrhagic shock at the final follow-up (p < 0.001). 
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Obtaining intravascular access in hypovolemic patients (especially trauma patients) 
should be done as soon as possible. In patients with hemorrhage, the most important part of 
the procedure is to stop the hemorrhage. In such a patient’s hospital setting, transfusion of 
blood substitutes should be limited in favor of the transfusion of blood components. It is 
recommended to transfuse the red blood cell concentrate in a volume that maintains the 
hemoglobin concentration at 7–9 g/dL. Fresh frozen plasma (FFP) should be transfused 
immediately at a dose of 10–15 mL/kg b.w. and further replenishment of FFP should depend 
on the volume of red blood cells transfused and the coagulogram. In the case of platelets, they 
should be transfused in sufficient quantities to maintain a concentration of 50,000/mL. To 
mitigate the effects of hypovolemic shock caused by the injury, transfusion of cryoprecipitate 
or fibrinogen concentrate may also be considered.  
Fluid therapy aims not only to maintain and restore the intravascular volume but also, 
by optimizing the preload, to increase cardiac output and improve tissue perfusion. 
Discussions are still ongoing as to whether crystalloids (i.e. 0.9% saline or Ringer’s Lactate) 
or colloidal solutions (i.e. dextran’s, gelatins, HAES) should be used in the initial phase of 
fluid resuscitation. De Crescenzo et al. [44] indicates no beneficial effect of hypertonic saline 
with or without dextran in general trauma patients. In turn, Martin et al. [45] in his meta-
analysis indicated that crystalloids were less efficient than colloids at stabilizing resuscitation 
endpoints. The application of an appropriate fluid resuscitation strategy is, therefore, more 
important than the type of fluid administered. Malbrain et al. [46] showed that a positive 
cumulative fluid balance is associated with IAH and worse outcomes. Hypotensive fluid 
resuscitation as shown by numerous studies may offer a survival benefit over conventional 
fluid resuscitation for trauma patients. It can also further reduce blood loss and thus blood 
product utilization. It can, therefore, be concluded that fluid resuscitation in trauma patients 
should be based on a specific compromise between too small a volume leading to 
hypoperfusion and too much hydration in patients, which may result in increased bleeding due 
to increased BP. The use of too large a volume of fluid can lead to “dilutive” hemorrhagic 
bleeding. 
As indicated by numerous randomized studies — as also confirmed by this meta-
analysis — hypovolemic fluid resuscitation can bring benefits in the management of the 
trauma patient [28, 29, 47]. However, it should be remembered that the hypotension should 
not last longer than one hour [22, 28]. It should be kept in mind that the rules of fluid 
resuscitation in trauma patients with concomitant craniocerebral trauma are different. 
Thereafter, as recommended by the National Institute for Health and Clinical Excellence 
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(NICE), it is important to increase BP (systolic BP 110–120 mmHg) as quickly as possible to 
secure proper brain perfusion and prevent secondary brain changes. 
In this meta-analysis, hypovolemic fluid resuscitation was associated with a higher 
incidence of thrombocytopenia, renal failure or anemia in comparison with conventional 
management. The above symptoms are closely related. Thrombocytopenia is the most 
frequently diagnosed hemorrhagic flaw and may lead to anemia. As many authors indicate, 
acute kidney injury is a common feature in patients with thrombocytopenia-associated 
multiple organ failure with incidences as high as 42% in disseminated intravascular 
coagulation, 58% in thrombocytopenic purpura and 100% in hemolytic uremic syndromes. 
[48–50]. On the other hand, in the case of conventional fluid resuscitation, a statistically 
significantly higher incidence of acute respiratory distress syndrome (ARDS) or multiple 
organ dysfunction syndrome (MODS) was observed. Jiang et al. [51] indicate that 
hypovolemic/restricted fluid resuscitation can effectively eliminate inflammatory factors, 
improve immune function, maintain the stability of blood components, and reduce the 
incidences of ARDS and MODS. In the case of hypotension fluid resuscitation, there was also 
a higher incidence of acute myocardial infarction, which may be caused by lower myocardial 
overload. 
 
Limitations of the study 
The present study has some limitations. First, only in several articles study groups are 
appropriate, in other articles the sample size is relatively small, which led to a wide 95% 
confidence interval. Second, two studies referred to MAP, the others to systolic blood 
pressure. 
 
CONCLUSIONS 
The present study findings show significant associations between hypotensive fluid 
resuscitation and a decreased risk of adverse events and cardiovascular mortality in 
hypovolemic shock trauma patients. There is an urgent need for a large multicenter 
randomized trial to confirm these findings.  
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Figure 1. Flow diagram showing stages of database searching and study selection as per 
PRISMA guidelines. 
 
Figure 2. Forest plot of hypotension versus. conventional fluid resuscitation, relative to 
mortality. The center of each square represents the relative risk for individual trials, and the 
corresponding horizontal line stands for a 95% confidence interval. The diamonds represent 
pooled results. 
 
Figure 3. Forest plot of hypotension versus conventional fluid resuscitation, relative to fluid 
balance and transfusion requirements. The center of each square represents the mean 
difference for individual trials, and the corresponding horizontal line stands for 95% 
confidence interval. The diamonds represent pooled results. 
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Table 1. Comparison of hypotension and conventional fluid resuscitation relative to adverse events. 
 Number of 
trials 
Hypotension fluid 
resuscitation 
Conventional 
fluid resuscitation 
RR or MD (95% CI) P value 
I2 statistic, 
% 
ARDS 13 7.8% 16.8% 0.44 [0.34–0.58] < 0.001 0% 
Acute myocardial infarction 1 1.3% 1.5% 0.88 [0.06–13.79] 0.93 – 
Stroke 1 0% 3.0% 0.18 [0.01–3.61] 0.26 – 
Sepsis syndrome 2 3.5% 3.9% 0.91 [0.42–1.98] 0.82 0% 
MODS 10 8.6% 21.6% 0.42 [0.30–0.60] < 0.001 0% 
Any renal failure 1 14.7% 12.1% 1.21 [0.52–2.83] 0.66 – 
Acute renal failure 8 8.8% 8.1% 0.99 [0.53–1.86] 0.98 61% 
Anemia 2 74.3% 68.6% 1.11 [0.96–1.28] 0.16 2% 
Hypotension 1 13.3% 16.7% 0.80 [0.36–1.76] 0.58 – 
Coagulopathy 3 15.7% 15.8% 0.95 [0.73–1.24] 0.73 0% 
Thrombocytopenia 2 33.6% 29.4% 1.21 [0.64–2.28] 0.56 54% 
Pneumonia 1 7.6% 9.1% 0.84 [0.49–1.43] 0.52 – 
Deterioration in T-RTS 1 7.4% 7.9% 0.93 [0.50–1.71] 0.81 – 
Complications not specified 1 7.5% 8.6% 0.88 [0.61–1.27] 0.49 – 
ARDS — acute respiratory distress syndrome; MORS — multiple organ dysfunction syndrome; MD — mean difference; RR — risk ratio 
 
 



